Invest1 distinct publisher3 min readUpdated
Unitree is pricing at roughly 36 times revenue while Shein seeks under one times. China's primary market is re-rating sectors wholesale, not picking companies.
The Investor · Invest desk

Compiled by The InvestorSomething wrong?How this is made
Two Chinese IPOs land in the same week and the smaller one is absorbing the attention. Unitree, the humanoid robotics maker, is raising 6.1 billion yuan ($904 million) on Shanghai's STAR market at a valuation of about $9 billion [1], while Shein is expected to begin its Hong Kong offering with shares possibly debuting as soon as Aug. 28, according to Reuters, seeking as much as $3 billion, roughly three times Unitree's target [2]. Per Fortune, retail investors are scrambling for Unitree and secondary markets are pricing a large post-debut jump [3].
The size gap makes the pricing gap more interesting. Unitree reported 1.7 billion yuan ($252 million) of 2025 revenue, four times its 2024 figure, with almost 45% from overseas, and net income of 600 million yuan ($89 million) [4][5]. Shein's prospectus shows $41.2 billion in 2025 revenue, up from $38.8 billion, and about $2 billion of profit [6]. That is roughly 160 times Unitree's revenue [7] and about 22 times its net income [8].
Now the valuations. Unitree's $9 billion is about 36 times revenue and roughly 100 times earnings [9][10]. Shein is targeting $25 billion to $30 billion according to reports from the Financial Times and Reuters [11], which is under one times revenue and roughly 13 to 15 times profit [12][13]. Shein's own target is about 57% below the $64 billion it fetched in 2024 and far below its $100 billion mark in 2022 [11][14]. Unitree said last week its retail tranche was more than 8,000 times oversubscribed [15].
What allocators are buying in Unitree is a sector, not a demonstrated end market. More than 70% of its humanoid units go to academic and research institutions, with some state-owned enterprises and large manufacturers experimenting [16]. The comparison set is unprofitable: Hong Kong-listed UBTech lost $104 million last year, and Boston Dynamics and Figure AI are also loss-making [17]. Smart Analytics Global, a California research firm, calculates Chinese firms shipped 97% of humanoid robots in the first half [18], and its report says Unitree is no longer the leader, with Shanghai's Agibot ahead and preparing a Hong Kong listing later this year [19].
What they are selling in Shein is a policy exposure. The U.S. ended de minimis duty exemptions last year and Europe followed in July [20]; Shein's prospectus concedes the EU effect could match or exceed what it saw in the U.S. [21]. Europe is now 35.4% of revenue against 24.1% from the U.S. [22]. Shein's abandoned New York attempt, which drew U.S. official scrutiny over forced-labour allegations in its supply chain, cost it time [23]. Growth of 6.2% at that scale is not a growth story [24].
Watch three things: whether Unitree's debut print holds once the retail scramble clears, whether Agibot's Hong Kong listing prices off Unitree's multiple or resets it, and what Shein's first quarter of post-de minimis European numbers does to a valuation already cut by more than half. Also watch the FCC's late-July ban on imported foreign humanoid and quadruped robots, justified on supply-chain and national-security grounds [25], which caps the addressable market these multiples assume.
Follow any of these and your For You feed starts watching them — no settings page required.
Ranked by verification strength, evidence, and original report placement.
Media reports from the Financial Times and Reuters suggest Shein is targeting a valuation between $25 billion and $30 billion, a deep discount from the $64 billion valuation it fetched in 2024 and the $100 billion valuation it got in 2022.
Unitree claimed last week that the retail portion of its offering was more than 8,000 times oversubscribed.
Unitree, a Chinese humanoid robotics maker, is raising 6.1 billion Chinese yuan ($904 million) in an IPO on Shanghai's STAR market at a market valuation of around $9 billion, with a trading debut expected this week.
Shein will reportedly start its Hong Kong IPO later this week with shares potentially debuting as soon as Aug. 28, according to Reuters, hoping to raise as much as $3 billion, roughly three times what Unitree is targeting.
Unitree reported 1.7 billion yuan ($252 million) in revenue last year, a fourfold increase from 2024, with almost 45% of revenue from overseas sales.
Unitree is profitable, with net income of 600 million yuan ($89 million) in 2025.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Hard financials, thin verification
The numeric core is specific and internally consistent: Unitree's raise, valuation, revenue, overseas mix and net income; Shein's prospectus revenue, profit and geographic split; UBTech's loss. The derived multiples follow arithmetically. But the cluster has one publisher and no primary documents are linked; the Shein valuation range is second-hand FT/Reuters reporting, the 8,000x oversubscription is the issuer's own claim, and the market-share ranking rests on a single research firm. Forward-looking elements (post-debut valuation jump, EU tariff impact) are unquantified.
Split: mass-market retailer vs research-lab robots
Adoption is bifurcated. Shein's $41.2 billion of revenue across Europe (35.4%) and the U.S. (24.1%) is genuine mass-market deployment. Unitree's is not: over 70% of its humanoids go to academic and research institutions, industrial buyers are only experimenting, and China-wide humanoid shipments — 97% of the global first half — reflect an early market where Unitree has already been passed by Agibot. Financial-market demand (8,000x retail oversubscription) is enthusiasm, not product uptake.
Robot multiple runs ahead of deployment
Positive gap: Unitree is priced at roughly 36 times revenue and about 100 times earnings, and the retail tranche was reportedly oversubscribed 8,000-fold, against a customer base that is over 70% academic and research, a lost shipment lead to Agibot, and a fresh U.S. import ban touching a company that draws ~45% of revenue from overseas. Shein sits on the other side — under one times sales for a $41.2 billion, ~$2 billion-profit business — which is why the story's own framing, that the market is re-rating sectors rather than companies, is the better-supported reading. Unitree's real profitability, unlike UBTech, Boston Dynamics or Figure AI, keeps the gap well short of pure froth.
Live offerings, self-reported demand
Almost every actor quoted has a stake in the price. Unitree is mid-offering and is itself the source of the 8,000x oversubscription figure; Shein's disclosures come from a prospectus written to support a Hong Kong listing, including its carefully hedged EU tariff warning; the reported $25-30 billion range arrives through media channels used by deal participants; Agibot's shipment leadership emerges as it prepares its own Hong Kong listing. The publisher's incentives are not disclosed in the source, but the sell-side pull on the underlying facts is unusually strong.
Arithmetic solid, framing single-sourced
High confidence in the reported and derived numbers, which are specific, attributed to prospectuses or named research, and arithmetically consistent. Lower confidence in the interpretive spine — the attention asymmetry, the predicted post-debut jump, and the causal story about capital rotating from e-commerce to AI hardware — all of which come from one publisher with no corroborating source in the cluster and no data behind the sentiment claims.
invest
Unitree's $905M Shanghai listing prices humanoids at 35x sales while profit halves1 distinct publisher
product
Unitree's $9bn Shanghai listing prices the humanoid story, not the robot-dog business1 distinct publisher
product
Unitree's CEO attached a falsifiable test to the "ChatGPT moment". Hold him to it1 distinct publisher
product
LG's humanoid is a 2027 promise; the Tennessee wheeled robot is the 2026 fact2 distinct publishers
Distinct publishers with included, body-backed reporting in this cluster.